Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:2001-2005, doi:10.1016/j.jacc.2009.08.018
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldberger, J. J.
Right arrow Articles by Passman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldberger, J. J.
Right arrow Articles by Passman, R.

QUARTERLY FOCUS ISSUE: HEART RHYTHM DISORDERS: VIEWPOINT

Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction

The Results Are Not Shocking

Jeffrey J. Goldberger, MD* and Rod Passman, MD, MSCE

Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Manuscript received April 13, 2009; revised manuscript received July 16, 2009, accepted August 10, 2009.

* Reprint requests and correspondence: Dr. Jeffrey J. Goldberger, Northwestern University Feinberg School of Medicine, 251 East Huron Street, Feinberg 8-503, Chicago, Illinois 60611 (Email: j-goldberger{at}northwestern.edu).

The risk of sudden death is highest early after myocardial infarction (MI) and progressively declines over the ensuing 6 to 12 months. Nevertheless, several randomized clinical trials have failed to show a survival benefit for implantable cardioverter-defibrillators when implanted early after MI in high-risk patients. The etiology of this acute MI–sudden cardiac death paradox is unclear, but may be related to the changing nature of the substrate over the several month period after acute MI. Further investigation is needed to delineate the actual causes of death in the early post-MI period and which interventions can be implemented to reduce the increased rate of sudden death that is observed.

Key Words: myocardial infarction • sudden death • implantable defibrillator

Abbreviations and Acronyms
  ICD = implantable cardioverter-defibrillator
  MI = myocardial infarction




This article has been cited by other articles:


Home page
J Med PhilosHome page
L. M. Fleck
Just Caring: Defining a Basic Benefit Package
J Med Philos, December 13, 2011; (2011) jhr052v1.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. Kadish and J. Goldberger
Selecting Patients for ICD Implantation: Are Clinicians Choosing Appropriately?
JAMA, January 5, 2011; 305(1): 91 - 92.
[Full Text] [PDF]


Home page
The ESC Textbook of Acute and Intensive Cardiac CareHome page
H.-R. Arntz
Chapter 2 Sudden cardiac death: epidemiology and prevention
The ESC Textbook of Acute and Intensive Cardiac Care, December 1, 2010; 1(1): med-9780199584314-chapter - med-9780199584314-chapter.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. M. Scirica, E. Braunwald, L. Belardinelli, C. M. Hedgepeth, J. Spinar, W. Wang, J. Qin, E. Karwatowska-Prokopczuk, F. W. A. Verheugt, and D. A. Morrow
Relationship Between Nonsustained Ventricular Tachycardia After Non-ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death: Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial
Circulation, August 3, 2010; 122(5): 455 - 462.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement